News | Published:

Wnt is back in drugmakers' sights, but is it druggable?

Nature Biotechnology volume 36, pages 10281029 (2018) | Download Citation


This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 30 November 2018

    In the version of this article initially published, Table 1 listed SM04554 as a Wnt pathway inhibitor; in fact, it is a Wnt pathway activator. The error has been corrected in the HTML and PDF versions of the article.

Author information


  1. Dublin, Ireland

    • Cormac Sheridan


  1. Search for Cormac Sheridan in:

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing